17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Selective Deletion of the Leptin Receptor in Dopamine Neurons Produces Anxiogenic-like Behavior and Increases Dopaminergic Activity in Amygdala

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Leptin receptors (Lepr) are expressed on midbrain dopamine neurons. However, the specific role of Lepr signaling in dopamine neurons remains to be clarified. In the present study, we generated a line of conditional knockout mice lacking functional leptin receptors selectively on dopamine neurons (Lepr DAT-Cre). These mice exhibit normal body weight and feeding. Behaviorally, Lepr DAT-Cre mice display an anxiogenic-like phenotype in the elevated plus-maze, light-dark box, social interaction and novelty-suppressed feeding tests. Depression-related behaviors in the chronic stress-induced anhedonia, forced swim and tail-suspension tests were not affected by deletion of Lepr in dopamine neurons. In vivo electrophysiological recordings of dopamine neurons in the ventral tegmental area (VTA) revealed an increase in burst firing in Lepr DAT-Cre mice. Moreover, blockade of D1-dependent dopamine transmission in the central amygdala by local microinjection of the D1 antagonist SCH23390 attenuated the anxiogenic phenotype of Lepr DAT-Cre mice. These findings suggest that leptin receptor signaling in midbrain dopamine neurons has a crucial role for the expression of anxiety and for the dopamine modulation of amygdala function.

          Related collections

          Most cited references79

          • Record: found
          • Abstract: not found
          • Article: not found

          Depression: a new animal model sensitive to antidepressant treatments.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation.

            This paper evaluates the validity, reliability and utility of the chronic mild stress (CMS) model of depression. In the CMS model, rats or mice are exposed sequentially, over a period of weeks, to a variety of mild stressors, and the measure most commonly used to track the effects is a decrease in consumption of a palatable sweet solution. The model has good predictive validity (behavioural changes are reversed by chronic treatment with a wide variety of antidepressants), face validity (almost all demonstrable symptoms of depression have been demonstrated), and construct validity (CMS causes a generalized decrease in responsiveness to rewards, comparable to anhedonia, the core symptom of the melancholic subtype of major depressive disorder). Overall, the CMS procedure appears to be at least as valid as any other animal model of depression. The procedure does, however, have two major drawbacks. One is the practical difficulty of carrying out CMS experiments, which are labour intensive, demanding of space, and of long duration. The other is that, while the procedure operates reliably in many laboratories, it can be difficult to establish, for reasons which remain unclear. However, once established, the CMS model can be used to study problems that are extremely difficult to address by other means.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The tail suspension test: a new method for screening antidepressants in mice.

              A novel test procedure for antidepressants was designed in which a mouse is suspended by the tail from a lever, the movements of the animal being recorded. The total duration of the test (6 min) can be divided into periods of agitation and immobility. Several psychotropic drugs were studied: amphetamine, amitriptyline, atropine, desipramine, mianserin, nomifensine and viloxazine. Antidepressant drugs decrease the duration of immobility, as do psychostimulants and atropine. If coupled with measurement of locomotor activity in different conditions, the test can separate the locomotor stimulant doses from antidepressant doses. Diazepam increases the duration of immobility. The main advantages of this procedure are the use of a simple, objective test situation, the concordance of the results with the validated "behavioral despair" test from Porsolt and the sensitivity to a wide range of drug doses.
                Bookmark

                Author and article information

                Journal
                9607835
                20545
                Mol Psychiatry
                Mol. Psychiatry
                Molecular psychiatry
                1359-4184
                1476-5578
                9 August 2012
                12 April 2011
                October 2011
                03 September 2012
                : 16
                : 10
                : 1024-1038
                Affiliations
                [1 ]Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229
                [2 ]Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229
                Author notes
                Correspondence should be addressed to Dr. Xin-Yun Lu, Department of Pharmacology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229 Phone: 210-567-0803 Fax: 210-567-4303 lux3@ 123456uthscsa.edu
                Article
                nihpa276134
                10.1038/mp.2011.36
                3432580
                21483433
                b222a251-ca2c-441e-808e-88cd9b91d9f6

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH076929-05 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH076929-04 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH076929-03 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH076929-02 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH076929-01A1 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH073844-05 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH073844-04 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH073844-03 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH073844-02 || MH
                Funded by: National Institute of Mental Health : NIMH
                Award ID: R01 MH073844-01A2 || MH
                Categories
                Article

                Molecular medicine
                leptin receptor,dopamine neurons,feeding,anxiety,ventral tegmental area,central amygdala

                Comments

                Comment on this article